Idiopathic myelofibrosis associated with dermatomyositis [4]

American Journal of Hematology

Volumn 81, Issue 7, 2006, Pages 559-560

  Muslimani, Alaa ^a   Ahluwalia, Manmeet S ^a   Palaparty, Poornanand ^b   Daw, Hamed A ^b  

^a FAIRVIEW HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DERMATOMYOSITIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; LETTER; MUSCLE BIOPSY; MYELOID METAPLASIA; PAPULE; PRIORITY JOURNAL; RASH; TELANGIECTASIA;

ANTI-INFLAMMATORY AGENTS; DERMATOMYOSITIS; FEMALE; HUMANS; MIDDLE AGED; MYELOFIBROSIS; PREDNISONE;

EID: 33745699064     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20594     Document Type: Letter

References (5)

1. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med 2000;342:1255.
2. Castro M, Conn DL, Su WP, Garton JP. Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol 1991;18:721-727.
3. Enright H, Miller W. Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma 1997;24:483-489.
4. Okamoto T, Okada M, Mori A, Saheki K, Takatsuka H, Wada H, Tamura A, Fujimori Y, Takemoto Y, Kanamaru A, Kakishita E. Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients. Int J Hematol 1997;66:345-351.
5. Cappio FC, Vigiliani R, Novarino, Camussi G, campana D, Gavosoyo F. Idiopathic myelofibrosis: a possible role for immune-complexes in the pathogenesis of bone marrow fibrosis. Br J Haematol 1981;49:17-21.